Cargando…
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
BACKGROUND: Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are both transmitted by the fecal-oral route and are known as the leading causes of acute viral hepatitis in the world, especially in developing countries. There is a lack of updated data on HAV and HEV seroprevalence in Iran. OBJECTIVE...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834187/ https://www.ncbi.nlm.nih.gov/pubmed/27110256 http://dx.doi.org/10.5812/hepatmon.32215 |
_version_ | 1782427457389854720 |
---|---|
author | Hesamizadeh, Khashayar Sharafi, Heidar Keyvani, Hossein Alavian, Seyed Moayed Najafi-Tireh Shabankareh, Azar Sharifi Olyaie, Roghiyeh Keshvari, Maryam |
author_facet | Hesamizadeh, Khashayar Sharafi, Heidar Keyvani, Hossein Alavian, Seyed Moayed Najafi-Tireh Shabankareh, Azar Sharifi Olyaie, Roghiyeh Keshvari, Maryam |
author_sort | Hesamizadeh, Khashayar |
collection | PubMed |
description | BACKGROUND: Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are both transmitted by the fecal-oral route and are known as the leading causes of acute viral hepatitis in the world, especially in developing countries. There is a lack of updated data on HAV and HEV seroprevalence in Iran. OBJECTIVES: The aim of this study was to determine the seroprevalence of HAV and HEV among a group of blood donors in Tehran, Iran. MATERIALS AND METHODS: A cross-sectional study was performed from July 2014 to December 2014, on a total of 559 blood donors referred to the Tehran blood transfusion center. The serum samples were tested for antibodies to HAV and HEV, using the enzyme-linked immunosorbent assay. RESULTS: In the present study, 536 (95.9%) cases were male and 23 (4.1%) female with mean age of 38 years. Out of 559 blood donors, 107 (19.1%) were first-time donors, 163 (29.2%) lapsed donors and 289 (51.7%) regular donors. Anti-HAV was found in 395 (70.7%) and anti-HEV in 45 (8.1%) of the blood donors. The HAV and HEV seroprevalence increased by age. There was no significant difference between genders in terms of anti-HAV and anti-HEV status. The HAV and HEV seroprevalence was significantly related to the level of education, where the donors with higher level of education had lower rate of HAV and HEV seroprevalence. The HAV and HEV seroprevalence was significantly higher in regular and lapsed donors than in first-time donors. CONCLUSIONS: The present study showed that both HAV and HEV infections are still endemic in Iran. |
format | Online Article Text |
id | pubmed-4834187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-48341872016-04-22 Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran Hesamizadeh, Khashayar Sharafi, Heidar Keyvani, Hossein Alavian, Seyed Moayed Najafi-Tireh Shabankareh, Azar Sharifi Olyaie, Roghiyeh Keshvari, Maryam Hepat Mon Research Article BACKGROUND: Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are both transmitted by the fecal-oral route and are known as the leading causes of acute viral hepatitis in the world, especially in developing countries. There is a lack of updated data on HAV and HEV seroprevalence in Iran. OBJECTIVES: The aim of this study was to determine the seroprevalence of HAV and HEV among a group of blood donors in Tehran, Iran. MATERIALS AND METHODS: A cross-sectional study was performed from July 2014 to December 2014, on a total of 559 blood donors referred to the Tehran blood transfusion center. The serum samples were tested for antibodies to HAV and HEV, using the enzyme-linked immunosorbent assay. RESULTS: In the present study, 536 (95.9%) cases were male and 23 (4.1%) female with mean age of 38 years. Out of 559 blood donors, 107 (19.1%) were first-time donors, 163 (29.2%) lapsed donors and 289 (51.7%) regular donors. Anti-HAV was found in 395 (70.7%) and anti-HEV in 45 (8.1%) of the blood donors. The HAV and HEV seroprevalence increased by age. There was no significant difference between genders in terms of anti-HAV and anti-HEV status. The HAV and HEV seroprevalence was significantly related to the level of education, where the donors with higher level of education had lower rate of HAV and HEV seroprevalence. The HAV and HEV seroprevalence was significantly higher in regular and lapsed donors than in first-time donors. CONCLUSIONS: The present study showed that both HAV and HEV infections are still endemic in Iran. Kowsar 2016-01-23 /pmc/articles/PMC4834187/ /pubmed/27110256 http://dx.doi.org/10.5812/hepatmon.32215 Text en Copyright © 2016, Kowsar Corp. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Research Article Hesamizadeh, Khashayar Sharafi, Heidar Keyvani, Hossein Alavian, Seyed Moayed Najafi-Tireh Shabankareh, Azar Sharifi Olyaie, Roghiyeh Keshvari, Maryam Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran |
title | Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran |
title_full | Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran |
title_fullStr | Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran |
title_full_unstemmed | Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran |
title_short | Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran |
title_sort | hepatitis a virus and hepatitis e virus seroprevalence among blood donors in tehran, iran |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834187/ https://www.ncbi.nlm.nih.gov/pubmed/27110256 http://dx.doi.org/10.5812/hepatmon.32215 |
work_keys_str_mv | AT hesamizadehkhashayar hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran AT sharafiheidar hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran AT keyvanihossein hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran AT alavianseyedmoayed hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran AT najafitirehshabankarehazar hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran AT sharifiolyaieroghiyeh hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran AT keshvarimaryam hepatitisavirusandhepatitisevirusseroprevalenceamongblooddonorsintehraniran |